SCHEMBL29560252

SCHEMBL29560252

O=S(=O)(Nc1cccc2c1OCO2)c1c[nH]c2cc(F)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.40
▸ TDO2 P48775 4/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ ACLY P53396 1/20 0.37
▸ TTBK1 Q5TCY1 1/20 0.37
▸ TTBK2 Q6IQ55 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ HTR1A P08908 3/20 0.36
▸ SLC6A4 P31645 3/20 0.36
▸ ABCB1 P08183 1/20 0.36
▸ FLT1 P17948 1/20 0.36
▸ MAP2K4 P45985 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ MAPKAPK2 P49137 1/20 0.36
▸ MAPKAPK3 Q16644 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20354833 1.00 DRD2 (0.40) DRD2TDO2HSP90AA1HSP90AB1ACLY
SCHEMBL29560443 0.87 HSP90AA1 (0.42) DRD2HSP90AA1HSP90AB1TTBK1TTBK2
SCHEMBL29560412 0.87 KDM4E (0.44) DRD2HSP90AA1HSP90AB1TTBK1TTBK2
SCHEMBL21545877 0.87 HSP90AA1 (0.42) DRD2HSP90AA1HSP90AB1TTBK1TTBK2
SCHEMBL20354830 0.87 KDM4E (0.44) DRD2HSP90AA1HSP90AB1TTBK1TTBK2
SCHEMBL29559966 0.85 EPHB4 (0.43) TDO2HSP90AA1HSP90AB1TTBK1TTBK2
SCHEMBL20354832 0.85 EPHB4 (0.43) TDO2HSP90AA1HSP90AB1TTBK1TTBK2
SCHEMBL20354768 0.81 KLK7 (0.39) HSP90AA1HSP90AB1ACLYTTBK1TTBK2
SCHEMBL20354683 0.77 TTBK1 (0.40) HSP90AA1HSP90AB1ACLYTTBK1TTBK2
SCHEMBL29559906 0.77 TTBK1 (0.40) HSP90AA1HSP90AB1ACLYTTBK1TTBK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12071404-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2024-08-27 — — US disclosed
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2023-11-21 — — US disclosed
US-20230348384-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides UCB PHARMA GMBH (DE) 2023-11-02 — — US disclosed
US-11345662-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2022-05-31 — — US disclosed
US-20220127227-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides UCB PHARMA GMBH (DE) 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127227-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides GPR17, GPR18, GPR27 DRD2 1510/4885TDO2 821/4885HSP90AA1 1989/4885
US-11345662-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 DRD2 1510/4885TDO2 821/4885HSP90AA1 1989/4885
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 DRD2 1510/4885TDO2 821/4885HSP90AA1 1989/4885
US-20230348384-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides GPR17, GPR18, GPR27 DRD2 1510/4885TDO2 821/4885HSP90AA1 1989/4885
US-12071404-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 DRD2 1510/4885TDO2 821/4885HSP90AA1 1989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback